Literature DB >> 20363219

Metabotropic glutamate receptor subtype 5 antagonism in learning and memory.

Agnes Simonyi1, Todd R Schachtman, Gert R J Christoffersen.   

Abstract

The role of the metabotropic glutamate receptor 5 (mGlu(5) receptor) in learning and memory and other behaviors are reviewed by examining the influence of selective antagonists and genetic knockout on performance. This receptor is involved in spatial learning, contextual fear conditioning, inhibitory avoidance, fear potentiated startle, and conditioned taste aversion. However, mGlu(5) receptor antagonists have proven to be ineffective in other learning tasks, such as the delayed-match-to-position test and a three-hole spatial learning task. Locomotion is often decreased by mGlu(5) receptor antagonists; and other behaviors such as social interaction and consummatory responses can also be affected. In mGlu(5) receptor knockout mice, performance in contextual fear conditioning and spatial water maze tasks is impaired. Although the available evidence is suggestive of an important contribution of mGlu(5) receptors to cognitive functions, further studies are needed, particularly those with in vivo evaluation of the role of mGlu(5) receptors in selective brain regions in different stages of memory formation. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363219      PMCID: PMC2892203          DOI: 10.1016/j.ejphar.2009.12.039

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  87 in total

1.  Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia.

Authors:  K Biber; D J Laurie; A Berthele; B Sommer; T R Tölle; P J Gebicke-Härter; D van Calker; H W Boddeke
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

2.  Effects of metabotropic glutamate receptor 5 on latent inhibition in conditioned taste aversion.

Authors:  Carla Bills; Todd R Schachtman; Peter Serfozo; Will P J M Spooren; Fabrizio Gasparini; Agnes Simonyi
Journal:  Behav Brain Res       Date:  2005-02-10       Impact factor: 3.332

3.  Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice.

Authors:  Margaret J Bradbury; Una Campbell; Darlene Giracello; Deborah Chapman; Chris King; Lida Tehrani; Nicholas D P Cosford; Jeff Anderson; Mark A Varney; Alison M Strack
Journal:  J Pharmacol Exp Ther       Date:  2004-12-08       Impact factor: 4.030

4.  2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.

Authors:  F Gasparini; K Lingenhöhl; N Stoehr; P J Flor; M Heinrich; I Vranesic; M Biollaz; H Allgeier; R Heckendorn; S Urwyler; M A Varney; E C Johnson; S D Hess; S P Rao; A I Sacaan; E M Santori; G Veliçelebi; R Kuhn
Journal:  Neuropharmacology       Date:  1999-10       Impact factor: 5.250

5.  Effects of mGlu1 and mGlu5 receptor antagonists on negatively reinforced learning.

Authors:  A Gravius; M Pietraszek; D Schäfer; W J Schmidt; W Danysz
Journal:  Behav Pharmacol       Date:  2005-03       Impact factor: 2.293

6.  SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5.

Authors:  M A Varney; N D Cosford; C Jachec; S P Rao; A Sacaan; F F Lin; L Bleicher; E M Santori; P J Flor; H Allgeier; F Gasparini; R Kuhn; S D Hess; G Veliçelebi; E C Johnson
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

7.  The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison.

Authors:  Theresa M Ballard; Marie L Woolley; Eric Prinssen; Jörg Huwyler; Richard Porter; Will Spooren
Journal:  Psychopharmacology (Berl)       Date:  2005-03-01       Impact factor: 4.530

8.  The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.

Authors:  Geoffrey B Varty; Mariagrazia Grilli; Angelo Forlani; Silva Fredduzzi; Michael E Grzelak; Donald H Guthrie; Robert A Hodgson; Sherry X Lu; Elisa Nicolussi; Annamarie J Pond; Eric M Parker; John C Hunter; Guy A Higgins; Angelo Reggiani; Rosalia Bertorelli
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

9.  Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities.

Authors:  Chang Z Zhu; Sonya G Wilson; Joseph P Mikusa; Carol T Wismer; Donna M Gauvin; James J Lynch; Carrie L Wade; Michael W Decker; Prisca Honore
Journal:  Eur J Pharmacol       Date:  2004-12-15       Impact factor: 4.432

10.  The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats.

Authors:  Una C Campbell; Kush Lalwani; Lisa Hernandez; Gene G Kinney; P Jeffrey Conn; Linda J Bristow
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

View more
  29 in total

1.  mGlu receptors and drug addiction.

Authors:  Richard M Cleva; M Foster Olive
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-01-20

Review 2.  Glutamatergic targets for new alcohol medications.

Authors:  Andrew Holmes; Rainer Spanagel; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2013-09-01       Impact factor: 4.530

3.  Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats.

Authors:  S W Fowler; A K Ramsey; J M Walker; P Serfozo; M F Olive; T R Schachtman; A Simonyi
Journal:  Neurobiol Learn Mem       Date:  2010-11-17       Impact factor: 2.877

4.  Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.

Authors:  Ji Won Um; Adam C Kaufman; Mikhail Kostylev; Jacqueline K Heiss; Massimiliano Stagi; Hideyuki Takahashi; Meghan E Kerrisk; Alexander Vortmeyer; Thomas Wisniewski; Anthony J Koleske; Erik C Gunther; Haakon B Nygaard; Stephen M Strittmatter
Journal:  Neuron       Date:  2013-09-04       Impact factor: 17.173

5.  Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome.

Authors:  E Lancaster; E Martinez-Hernandez; M J Titulaer; M Boulos; S Weaver; J-C Antoine; E Liebers; C Kornblum; C G Bien; J Honnorat; S Wong; J Xu; A Contractor; R Balice-Gordon; J Dalmau
Journal:  Neurology       Date:  2011-10-19       Impact factor: 9.910

Review 6.  Overview of glutamatergic neurotransmission in the nervous system.

Authors:  Mark J Niciu; Benjamin Kelmendi; Gerard Sanacora
Journal:  Pharmacol Biochem Behav       Date:  2011-08-26       Impact factor: 3.533

7.  The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease.

Authors:  Juliana G Doria; Jessica M de Souza; Flavia R Silva; Isabella G Olmo; Toniana G Carvalho; Juliana Alves-Silva; Talita H Ferreira-Vieira; Jessica T Santos; Claudymara Q S Xavier; Nathalia C Silva; Esther M A Maciel; Peter Jeffrey Conn; Fabiola M Ribeiro
Journal:  J Neurochem       Date:  2018-09-11       Impact factor: 5.372

8.  The mGluR5 Positive Allosteric Modulator CDPPB Does Not Alter Extinction or Contextual Reinstatement of Methamphetamine-Seeking Behavior in Rats.

Authors:  John J Widholm; Justin T Gass; Richard M Cleva; M Foster Olive
Journal:  J Addict Res Ther       Date:  2011-12-24

Review 9.  Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction.

Authors:  Daniela Neuhofer; Peter Kalivas
Journal:  Neurobiol Learn Mem       Date:  2018-02-09       Impact factor: 2.877

10.  The memory-enhancing effects of hippocampal estrogen receptor activation involve metabotropic glutamate receptor signaling.

Authors:  Marissa I Boulware; John D Heisler; Karyn M Frick
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.